Patents by Inventor Jerome Bibette

Jerome Bibette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190317085
    Abstract: The invention describes a method for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, comprising the steps of: a) compartmentalising the compounds into microcapsules together with the target, such that only a subset of the repertoire is represented in multiple copies in any one microcapsule; and b) identifying the compound which binds to or modulates the activity of the target; wherein at least one step is performed under microfluidic control. The invention enables the screening of large repertoires of molecules which can serve as leads for drug development.
    Type: Application
    Filed: June 26, 2019
    Publication date: October 17, 2019
    Inventors: Andrew David Griffiths, David A. Weitz, Darren Roy Link, Keunho Ahn, Jerome Bibette
  • Publication number: 20190240138
    Abstract: The invention deals with a dispersion of drops of a first phase in a second phase substantially immiscible with the first phase, the solubility of the first phase in the second phase being less than 5% by mass. Each drop includes a core formed with a first phase and a shell formed with a coacervate layer interposed between the first phase and the second phase. The coacervate layer comprises a first precursor polymer of the coacervate and a second precursor polymer of the coacervate, one of the first phase and of the second phase is aqueous, and the other of the first phase and of the second phase is oily.
    Type: Application
    Filed: April 15, 2019
    Publication date: August 8, 2019
    Inventors: Mathieu GOUTAYER, Jerome BIBETTE
  • Patent number: 10371699
    Abstract: The invention describes a method for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, comprising the steps of: a) compartmentalizing the compounds into microcapsules together with the target, such that only a subset of the repertoire is represented in multiple copies in any one microcapsule; and b) identifying the compound which binds to or modulates the activity of the target; wherein at least one step is performed under microfluidic control. The invention enables the screening of large repertoires of molecules which can serve as leads for drug development.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: August 6, 2019
    Assignees: President and Fellows of Harvard College, United Kingdom Research and Innovation
    Inventors: Andrew David Griffiths, David A. Weitz, Darren Roy Link, Keunho Ahn, Jerome Bibette
  • Publication number: 20190170741
    Abstract: The present invention relates to the field of biological diagnosis in oncology. It relates to a method and apparatus for detecting and/or characterizing tumor cells by detecting one or more elements of the tumor cell secretome, in particular one or more peptides or proteins, and, in particular, one or more tumor markers. The invention also relates to detecting and/or characterizing droplets of tumor cells and their method of preparation.
    Type: Application
    Filed: April 18, 2017
    Publication date: June 6, 2019
    Inventors: Catherine Michèle Marilou ALIX - PANABIERES, Andrew David GRIFFITHS, Raphaël Clément Li-Ming DOINEAU, Clément NIZAK, Philippe Chi-Thanh NGHE, Jean-Marie Pierre BAUDRY, Elodie Michèle Christine BRIENT-LITZLER, Klaus EYER, Jérôme BIBETTE
  • Patent number: 10300006
    Abstract: This method includes the provision of a first fluid (36) including the first phase and a first precursor polymer of the coacervate contained in the first phase, and the formation of drops of the first fluid (36) in a second fluid (40) intended to form the second phase (16). It includes the steps of introducing a second precursor polymer of the coacervate into the second fluid (40) and, during the formation of each drop (12), or once each drop (12) has been formed, for generating the coacervate layer by interaction between the first precursor polymer and the second precursor polymer at the interface between the first phase (14) and the second phase (16).
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: May 28, 2019
    Assignee: CAPSUM
    Inventors: Mathieu Goutayer, Jerome Bibette
  • Publication number: 20190111432
    Abstract: The present invention relates to a method for selecting and recovering products, comprising the following steps: providing an emulsion (6) comprising a plurality of drops (4) contained in a carrier fluid (10), each drop comprising an internal fluid (8), measuring at least one physical parameter for several drops (4) of the emulsion (6), classifying at least some of the drops (4) of the emulsion in a class based on measurements obtained during the measuring step, tagging at least some of the classified drops (4) based on the class of the drop (4), selectively recovering the drop (4) or part of the drop (4) using the tag of the drop or part of the drop (4).
    Type: Application
    Filed: April 14, 2017
    Publication date: April 18, 2019
    Inventors: Jean BAUDRY, Jérôme BIBETTE, Laurent BOITARD, Klaus EYER, Krzysztof LANGER
  • Patent number: 10253188
    Abstract: A composition to cover a metal surface comprises an organic continuous phase comprising at least one anticorrosive pigment, and a hydrophilic phase dispersed in the organic continuous phase, the hydrophilic phase comprising a chemical agent for the surface treatment of the metal surface. The surface treatment chemical agent can advantageously be cerium nitrate. A process for the manufacture of a composition according to the present invention is provided.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: April 9, 2019
    Assignee: SOCIETE NOUVELLE DES COULEURS ZINCIQUES
    Inventors: Christelle Berteloot, Ludovic Mavel, Alexander Gibb, Jérôme Bibette, Damien Demoulin
  • Publication number: 20190046941
    Abstract: The present invention relates to a method for preparing solid microcapsules, comprising the steps of: a) adding under agitation a composition C1 comprising at least one active material to a cross-linkable liquid composition C2, wherein the active material is an additive to be used in the oil industry, composition C1 and composition C2 being immiscible with each other, so that a first emulsion is obtained, said first emulsion comprising droplets of composition C1 dispersed in composition C2, b) adding under agitation the first emulsion obtained in step a) to a liquid composition C3, composition C3 and composition C2 being immiscible with each other, so that a second emulsion is obtained, said second emulsion comprising droplets dispersed in composition C3, c) loading the second emulsion obtained in step b) in a mixer which applies a homogeneous controlled shear rate to said second emulsion, said shear rate being from 1 000 s?1 to 100 000 s?1, so that a third emulsion is obtained, said third emulsion comprising
    Type: Application
    Filed: September 16, 2016
    Publication date: February 14, 2019
    Applicant: TOTAL MARKETING SERVICES
    Inventors: Denis LANCON, Richard VERNAY, Jérôme BIBETTE, Damien DÉMOULIN, Jamie WALTERS
  • Publication number: 20190024261
    Abstract: The invention describes a method for the synthesis of compounds comprising the steps of: (a) compartmentalizing two or more sets of primary compounds into microcapsules; such that a proportion of the microcapsules contains two or more compounds; and (b) forming secondary compounds in the microcapsules by chemical reaction between primary compounds from different sets; wherein one or both of steps (a) and (b) is performed under microfluidic control; preferably electronic microfluidic control. The invention further allows for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, and which is co-compartmentalized into the microcapsules.
    Type: Application
    Filed: December 8, 2017
    Publication date: January 24, 2019
    Applicants: President and Fellows of Harvard College, Medical Research Council
    Inventors: Andrew David Griffiths, David A. Weitz, Darren Roy Link, Keunho Ahn, Jerome Bibette
  • Patent number: 10143650
    Abstract: A dispersion including a plurality of bodies dispersed in a continuous phase. Each dispersed body including an internal drop formed with an internal phase miscible with the continuous phase, the internal drop (16) receiving an active product. Each dispersed body including, around the internal drop, a membrane formed with an intermediate phase immiscible with the continuous phase and totally surrounding the internal drop. The ratio R1 of the average thickness (e) of the membrane over the average transverse dimension (Dc) of the active volume delimited by the internal drop and the membrane is greater than 0.05, and is advantageously less than 0.5. The ratio R2 of the partition coefficient of the active product between the intermediate phase forming the membrane and the internal phase forming the internal drop over the viscosity of the membrane is less than 1 s?1·Pa?1.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: December 4, 2018
    Assignee: CAPSUM
    Inventors: Jérôme Bibette, Thomas Delmas, Enric Santanach Carreras, Leslie Rolland
  • Patent number: 10107801
    Abstract: The present invention relates to a flow assay method in a liquid medium for an object (or element) of interest via the formation of aggregates of particles that are surface-functionalized by at least one functionalizing molecule, or receptor, specific for said object of interest.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: October 23, 2018
    Assignees: HORIBA ABX SAS
    Inventors: Aurelien Daynes, Gilles Cauet, Jean-Philippe Gineys, Philippe Nerin, Jerome Bibette
  • Patent number: 10092506
    Abstract: The present invention relates to a therapeutic agent formulation in the form of a nano-emulsion, comprising a continuous aqueous phase and at least one dispersed oily phase, in which the oily phase comprises further to the therapeutic agent, at least one amphiphilic lipid and at least one solubilizing lipid, and in which the aqueous phase comprises at least one polyalkoxylated cosurfactant. The invention also relates to a preparation method and use of this formulation.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: October 9, 2018
    Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Veronique Mourier-Robert, Jerome Bibette, Mathieu Goutayer, Fabrice Navarro y Garcia, Isabelle Texier-Nogues
  • Publication number: 20180272294
    Abstract: The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 27, 2018
    Inventors: Andrew David Griffiths, David A. Weitz, Darren Roy Link, Keunho Ahn, Jerome Bibette
  • Publication number: 20180272299
    Abstract: The invention describes a method for the synthesis of compounds comprising the steps of: (a) compartmentalising two or more sets of primary compounds into microcapsules; such that a proportion of the microcapsules contains two or more compounds; and (b) forming secondary compounds in the microcapsules by chemical reactions between primary compounds from different sets; wherein one or both of steps (a) and (b) is performed under microfluidic control; preferably electronic microfluidic control The invention further allows for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, and which is co-compartmentalised into the microcapsules.
    Type: Application
    Filed: March 15, 2018
    Publication date: September 27, 2018
    Applicants: President and Fellows of Harvard College, Medical Research Council
    Inventors: Andrew David Griffiths, David A. Weitz, Darren Roy Link, Keunho Ahn, Jerome Bibette
  • Patent number: 10073086
    Abstract: The present invention concerns a device for analyzing biological parameters from a sample (6) comprising (i) first transferring means (5, 20, 25), (ii) first preparing means (7), (iii) means for measuring cellular components (8), (iv) second preparing means (10, 11, 22, 23, 24) capable of carrying out, on a sample from the first preparing means (7), at least one dilution with an assay reagent (R3) comprising particles functionalized at the surface with at least one ligand specific to at least one analyte of interest, (v) immunodetection measurement means (30, 31) capable of assaying at least one analyte of interest by measuring the aggregation of functionalized particles, said device further comprising (i) second transferring means (4, 21, 22, 26) at least partially separate from the first transferring means (5, 20, 25) and (ii) means for applying a magnetic field (28) capable of causing, by magnetic interaction, an acceleration of the aggregation of said functionalized particles, which comprise magnetic coll
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: September 11, 2018
    Assignee: HORIBA ABX SAS
    Inventors: Jèrôme Bibette, Philippe Nerin, Jean-Philippe Gineys, Gilles Cauet
  • Publication number: 20180193829
    Abstract: The invention relates to a method for recuperating droplets (4), includes: supplying a chip (20) comprising a fluid circulation duct (46), injecting an emulsion (6) of droplets, injecting a carrier fluid (26) to form a working fluid (28) containing droplets of the emulsion which are spaced apart along the duct, conveying the working fluid through the duct, injecting a separating fluid (33) in order to separate the working fluid into a plurality of successive pockets (35), wherein each pocket is isolated from the next pocket by a separator (80), conveying the pockets and separators towards an outlet (66) of the chip, recuperating in a compartment (82) of a recuperation support (34) at least one pocket containing a droplet recuperated after conveying.
    Type: Application
    Filed: July 7, 2016
    Publication date: July 12, 2018
    Inventors: Laurent BOITARD, Nicolas BREMOND, Jaïro GARNICA RODRIGUEZ, Jérôme BIBETTE
  • Publication number: 20180185809
    Abstract: A method for preparing solid microcapsules, comprising the steps of adding under agitation a composition C1 comprising at least one active material to a cross-linkable liquid composition C2, the active material is not an additive to be used in the lubricant, fuel or bitumen industries, drilling sludges or muds, or oil exploration/production, compositions C1 and C2 being immiscible with each other. A first emulsion is obtained comprising droplets of composition C1 dispersed in composition C2, adding under agitation the first emulsion to a liquid composition C3, composition C3 and composition C2 being immiscible with each other, to obtain a second emulsion comprising droplets dispersed in composition C3.
    Type: Application
    Filed: September 16, 2016
    Publication date: July 5, 2018
    Applicant: CALYXIA
    Inventors: Jamie WALTERS, Damien DEMOULIN, Jérôme BIBETTE
  • Patent number: 9925501
    Abstract: The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: March 27, 2018
    Assignees: Medical Research Council, President and Fellows of Harvard College
    Inventors: Andrew David Griffiths, David A. Weitz, Darren R. Link, Keunho Ahn, Jerome Bibette
  • Patent number: 9925504
    Abstract: The invention describes a method for the synthesis of compounds comprising the steps of: (a) compartmentalizing two or more sets of primary compounds into microcapsules; such that a proportion of the microcapsules contains two or more compounds; and (b) forming secondary compounds in the microcapsules by chemical reactions between primary compounds from different sets; wherein one or both of steps (a) and (b) is performed under microfluidic control; preferably electronic microfluidic control The invention further allows for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, and which is co-compartmentalized into the microcapsules.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: March 27, 2018
    Assignees: President and Fellows of Harvard College, Medical Research Council
    Inventors: Andrew Griffiths, David Weitz, Keunho Ahn, Darren Link, Jerome Bibette
  • Patent number: 9919277
    Abstract: The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: March 20, 2018
    Assignees: Medical Research Council, President and Fellows of Harvard College
    Inventors: Andrew David Griffiths, David A. Weitz, Darren Roy Link, Keunho Ahn, Jerome Bibette